logo
  

Magellan Health Issues 2015 Guidance - Quick Facts

Magellan Health Inc. (MGLN) announced it expects to generate net revenue in the range of $4.25 billion to $4.49 billion, and net income in the range of $51 million to $67 million, or in the range of $1.90 to $2.50 per share, for 2015. Adjusted net income for 2015 is expected to be in the range of $88 million to $100 million, or in the range of $3.28 to $3.73 per share.

Analysts polled by Thomson Reuters expect the company to report earnings per share of $2.67 on revenue of $4.47 billion. Analysts' estimates typically exclude special items.

The company expects segment profit to be in the range of $265 million to $285 million. Cash flow from operations is expected to be in the range of $171 million to $195 million.

"Looking ahead to 2015, We are projecting revenue growth of slightly less than 20 percent, and expect to report revenues of over $4 billion for the first time in the company's history. We are reiterating our long-term compound annual growth objectives for both revenue and adjusted EPS of more than 20 percent, and for segment profit of more than 15 percent. Our 2015 plan and guidance represent a meaningful step forward towards these long-term goals," said Jonathan Rubin, CFO.

The company confirmed its 2014 guidance, which was most recently updated in October.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Consumer Product Safety Commission or CPSC has announced recalls including earmuffs, racer car toys, log splitters and cylinder kits, hampshire cribs, and air rifles, citing various reasons. 3M Co. has recalled Peltor X4 Series Earmuffs citing risk of overexposure to loud noise and sound, while Santa Monica, California -based JAKKS Pacific Inc. has called back children's Mario Kart... Lincoln Park, New Jersey -based ConSup North America Inc. is recalling around 85,984 pounds of ready-to-eat or RTE sliced prosciutto ham product produced in Germany without the benefit of equivalent inspection, the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS announced. French drug major Sanofi reported Thursday weak profit in its first quarter, despite higher net sales. The company also maintained its fiscal 2024 outlook. Sanofi shares were gaining around 4 percent in Paris trading as well as in pre-market activity on the Nasdaq.

A busy week for economics saw the release of first quarter growth figures for the U.S. economy and the interest rate decision in Japan. Read our stories to find out why the GDP data damped market sentiment in the U.S. and what were the signals given out by the Bank of Japan. Other news this week included new home sales data and jobless claims figures from the U.S., and the latest purchasing managers' survey results for the Eurozone.

View More Videos
Follow RTT